Literature DB >> 15913006

Regulation of hypothalamic-pituitary-adrenal activity in response to cognitive therapy in patients with generalized anxiety disorder.

Gustavo E Tafet1, Diego J Feder, Denise P Abulafia, Silvia S Roffman.   

Abstract

The aim of this study was to evaluate the efficacy of cognitive therapy (CT) in the treatment of generalized anxiety disorder (GAD), as it would be reflected through both psychological and psychoneuroendocrinological parameters. For this purpose, a group of outpatients with GAD were treated with CT for up to a maximum of 24 sessions. In order to assess psychological and biological changes, anxiety-related symptoms were evaluated according to the Hamilton Anxiety Rating Scale (HAM-A), and the hypothalamic-pituitary-adrenal (HPA) function was determined through assessment of circulating cortisol levels. A significant decrease in the HAM-A scores, along with significant changes in plasma cortisol levels, were observed after completion of treatment with CT. These observations contribute to demonstrate that the effect of certain psychotherapeutic approaches, such as CT, may be observed at both psychological and biological levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15913006     DOI: 10.3758/cabn.5.1.37

Source DB:  PubMed          Journal:  Cogn Affect Behav Neurosci        ISSN: 1530-7026            Impact factor:   3.282


  13 in total

1.  Enhancement of serotonin uptake by cortisol: a possible link between stress and depression.

Authors:  G E Tafet; M Toister-Achituv; M Shinitzky
Journal:  Cogn Affect Behav Neurosci       Date:  2001-03       Impact factor: 3.282

Review 2.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

3.  Correlation between cortisol level and serotonin uptake in patients with chronic stress and depression.

Authors:  G E Tafet; V P Idoyaga-Vargas; D P Abulafia; J M Calandria; S S Roffman; A Chiovetta; M Shinitzky
Journal:  Cogn Affect Behav Neurosci       Date:  2001-12       Impact factor: 3.282

4.  A healthy body in a healthy mind--and vice versa--the damaging power of "uncontrollable" stress.

Authors:  G P Chrousos; P W Gold
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

Review 5.  Psychotherapy for generalized anxiety disorder.

Authors:  T D Borkovec; A M Ruscio
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

Review 6.  Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1)

Authors:  P W Gold; F K Goodwin; G P Chrousos
Journal:  N Engl J Med       Date:  1988-08-11       Impact factor: 91.245

7.  Cortisol secretion in endogenous depression. I. Basal plasma levels.

Authors:  U Halbreich; G M Asnis; R Shindledecker; B Zumoff; R S Nathan
Journal:  Arch Gen Psychiatry       Date:  1985-09

Review 8.  Treatment of generalized anxiety disorder.

Authors:  Jack M Gorman
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

9.  Adrenocortical and behavioral responses to repeated stressors: toward an animal model of chronic stress and stress-related mental illness.

Authors:  J E Ottenweller; B H Natelson; D L Pitman; S D Drastal
Journal:  Biol Psychiatry       Date:  1989-12       Impact factor: 13.382

Review 10.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.

Authors:  G P Chrousos; P W Gold
Journal:  JAMA       Date:  1992-03-04       Impact factor: 56.272

View more
  10 in total

1.  An exploratory study of salivary cortisol changes during chamomile extract therapy of moderate to severe generalized anxiety disorder.

Authors:  John R Keefe; Wensheng Guo; Qing S Li; Jay D Amsterdam; Jun J Mao
Journal:  J Psychiatr Res       Date:  2017-10-16       Impact factor: 4.791

Review 2.  Childhood stressful events, HPA axis and anxiety disorders.

Authors:  Carlo Faravelli; Carolina Lo Sauro; Lucia Godini; Lorenzo Lelli; Laura Benni; Francesco Pietrini; Lisa Lazzeretti; Gabriela Alina Talamba; Giulia Fioravanti; Valdo Ricca
Journal:  World J Psychiatry       Date:  2012-02-22

Review 3.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

4.  Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.

Authors:  Michael W Otto; R Kathryn McHugh; Kathleen M Kantak
Journal:  Clin Psychol (New York)       Date:  2010-06-08

Review 5.  New research on anxiety disorders in the elderly and an update on evidence-based treatments.

Authors:  Carmen Andreescu; Daniel Varon
Journal:  Curr Psychiatry Rep       Date:  2015-07       Impact factor: 5.285

Review 6.  Why Does Psychotherapy Work and for Whom? Hormonal Answers.

Authors:  Susanne Fischer; Sigal Zilcha-Mano
Journal:  Biomedicines       Date:  2022-06-09

7.  Childhood parental loss and adult hypothalamic-pituitary-adrenal function.

Authors:  Audrey R Tyrka; Lauren Wier; Lawrence H Price; Nicole Ross; George M Anderson; Charles W Wilkinson; Linda L Carpenter
Journal:  Biol Psychiatry       Date:  2008-03-12       Impact factor: 13.382

8.  Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder.

Authors:  Rose C Mantella; Meryl A Butters; Janet A Amico; Sati Mazumdar; Bruce L Rollman; Amy E Begley; Charles F Reynolds; Eric J Lenze
Journal:  Psychoneuroendocrinology       Date:  2008-04-14       Impact factor: 4.905

9.  Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial.

Authors:  Christopher B Rosnick; Julie L Wetherell; Kamila S White; Carmen Andreescu; David Dixon; Eric J Lenze
Journal:  J Consult Clin Psychol       Date:  2016-02-15

Review 10.  Biological markers of generalized anxiety disorder.

Authors:  Eduard Maron; David Nutt
Journal:  Dialogues Clin Neurosci       Date:  2017-06       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.